• / Free eNewsletters & Magazine
  • / My Account
Home>Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger

Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger

3party Content

Tue, 21 Apr 2015

By Nicholas Casey And Orr Hirschauge TEL AVIV-- Teva Pharmaceutical Industries Ltd.'s $40 billion offer for Mylan NV marks corporate Israel's biggest foreign foray and caps years of hand-wringing about the inability of the country to nurture big multinationals, analysts say. Israel, the
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.